Roivant Sciences Ltd (ROIV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 03/31
| 06-2022 | 03-2022 | 12-2021 | 09-2021 | 06-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 1,946,168 | 2,060,400 | 2,217,199 | 2,500,191 | 1,999,444 |
| Other current assets | 93,274 | 86,123 | 70,334 | 55,563 | 58,165 |
| TOTAL | $2,039,442 | $2,146,523 | $2,287,533 | $2,555,754 | $2,057,609 |
| Non-Current Assets | |||||
| PPE Net | 31,689 | 25,905 | 21,606 | 16,904 | 15,550 |
| Investments And Advances | 301,287 | 325,834 | 398,743 | 436,780 | 280,922 |
| Intangibles | 145,430 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 82,550 | 86,867 | 91,493 | 93,468 | 100,616 |
| TOTAL | $560,956 | $438,606 | $511,842 | $547,152 | $397,088 |
| Total Assets | $2,600,398 | $2,585,129 | $2,799,375 | $3,102,906 | $2,454,697 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 33,304 | N/A | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | 161,304 | 34,583 | 24,358 | 77,158 | 15,014 |
| Accrued Expenses | 109,354 | 127,531 | 112,679 | 104,111 | 73,788 |
| Other current liabilities | 4,084 | 10,855 | 12,435 | 110,657 | 108,301 |
| TOTAL | $328,915 | $184,367 | $160,713 | $303,444 | $209,158 |
| Non-Current Liabilities | |||||
| Long Term Debt | 383,720 | 210,025 | 204,042 | 199,869 | 186,350 |
| Deferred Revenues | 9,011 | N/A | N/A | N/A | N/A |
| Other Non-Current Liabilities | 141,201 | 173,045 | 208,907 | 188,344 | 120,743 |
| TOTAL | $516,092 | $361,819 | $391,400 | $371,054 | $288,198 |
| Total Liabilities | $845,007 | $546,186 | $552,113 | $674,498 | $497,356 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 703,625 | N/A | N/A | N/A | N/A |
| Retained earnings | -3,095,533 | -2,763,724 | -2,493,662 | -2,209,126 | -2,000,645 |
| Other shareholders' equity | 376,300 | 381,053 | 380,472 | 391,674 | 133,012 |
| TOTAL | $1,755,391 | $2,038,943 | $2,247,262 | $2,428,408 | $1,957,341 |
| Total Liabilities And Equity | $2,600,398 | $2,585,129 | $2,799,375 | $3,102,906 | $2,454,697 |